Liya Gavasheli
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
06.10.2020
A pigment from ancient Egypt for modern microscopy
Egyptian Blue is one of the oldest artificially produced color pigments. It adorns for example the crown of the world-famous bust of Nefertiti. But the pigment can do even more. […]
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]